medicrea
-
Spine
Medicrea to Host Key Opinion Leader Breakfast in New York City for Investors Focused on Advances in the Personalized Spine Market
December 08, 2016 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA Group (Alternext Paris: FR0004178572 – ALMED), worldwide leader pioneering the…
Read More » -
Spine
MEDICREA Achieves Personalized Spine Milestone with 1,000 Patient-Specific UNiD™ Rod Procedures
November 28, 2016 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA Group (Alternext Paris: FR0004178572 – ALMED), worldwide leader pioneering the…
Read More » -
Hospitals
Medicrea Announces 2 FDA Clearances of New Specialized Components for Pediatric Deformity on PASS® and LigaPASS® Platforms for Complex Spine in Younger Patients
October 20, 2016 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Alternext Paris: FR0004178572 – ALMED), worldwide leader pioneering the…
Read More » -
Financial
Medicrea Announces 2016 Third-Quarter Sales
October 06, 2016 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Alternext Paris: FR0004178572 – ALMED), worldwide leader pioneering the…
Read More » -
Financial
Medicrea Announces Results for the 1st Half of 2016
September 22, 2016 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Paris: ALMED) (Alternext Paris: FR0004178572 – ALMED), pioneering the…
Read More » -
Financial
Medicrea raises $22m, taps Globus Medical co-founder Kienzle
AUGUST 10, 2016 BY BRAD PERRIELLO Medicrea (EPA:ALMED) said it raised a funding round worth about $22.3 million for its…
Read More » -
Financial
Medicrea H1 Revenue Rises 7% to 14.8 Million Euros
LYON, FRANCE AND NEW YORK, NY (PRWEB) JULY 11, 2016 The Medicrea Group (Alternext Paris: FR0004178572 – ALMED), PEA- PME…
Read More » -
Spine
MEDICREA Announces FDA Approval of First Patient-Specific UNiD™ Cervical Rod for Spine Surgery (Video)
LYON, France & NEW YORK–(BUSINESS WIRE)–MEDICREA®, (Paris:ALMED) (Alternext Paris: FR0004178572 – ALMED) the only medical device company offering patient-specific implant…
Read More » -
Spine
Taking customization to a new level — Medicrea manufactures spinal rods for individual patients
Written by Megan Wood Every person’s spine is unique. Lyon, France-based Medicrea understands an individual’s spine requires customized implants,…
Read More » -
Financial
MEDICREA: 2015 Annual Results and Q1 2016 Sales
LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA group (Paris:ALMED) (Alternext Paris: FR0004178572 – ALMED), PEA-PME eligible, which specializes in the…
Read More » -
Medicrea® Celebrates 500 UNID Surgeries and Launches Real-Time Support for Patient-Specific Spine Surgery
LYON, France & NEW YORK–(BUSINESS WIRE)–MEDICREA® (Paris:ALMED) (Alternext Paris: FR0004178572-ALMED), the leading medical device company for developing patient-specific solutions for…
Read More » -
Spine
MEDICREA names new VP of sales in US: 4 key points
By Megan Wood The MEDICREA group, a Lyon, France-headquartered manufacturer of surgical technologies for spinal pathologies, appointed Gregory Rhinehart as…
Read More » -
Financial
MEDICREA: Results for the 1st Half of 2015
LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA group (Alternext Paris:FR0004178572 – ALMED,PEA-PME eligible), which specializes in the development and manufacturing…
Read More » -
FDA CLEARS FIRST PATIENT-SPECIFIC SPINAL ROD
Walter Eisner • Thu, November 13th, 2014 Print this article The French-based Medicrea Group says it has received FDA 510(k)…
Read More » -
Spine
FDA Clears Next-Generation SURGIMAP 2.0 Software, First Pre-Operative Planning Platform for Personalized Spinal Implants
NEW YORK–(BUSINESS WIRE)–NEMARIS, Inc. today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)…
Read More »